ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Astec LifeSciences (ASTEC.NSE)
Astec LifeSciences share price today, ATLAS forecast and fair value
Basic Materials · Agricultural Inputs · National Stock Exchange of India · India
₹652.85▼ -1.63%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Astec LifeSciences in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Astec LifeSciences
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Astec LifeSciences a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹576.99 and ₹721.57; in 9 out of 10, between ₹473.24 and ₹879.76. Estimated annual volatility is 69%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹15.5B
- Market cap (USD)
- $164M
- P/E ratio
- 399.5
- Dividend yield
- 0.86%
- 52-week high
- ₹941.75
- 52-week low
- ₹513.40
- Revenue (12 months)
- ₹4.4B
- Operating margin
- -14.0%
- Net margin
- -15.1%
- Beta
- 0.15
What this means
ATLAS does not publish a fair value for ASTEC.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks ASTEC.NSE has traded between ₹513.40 and ₹941.75. Today it is 30.7% below that high and 27% above its low.
On the business: net margin is 15.1%; it trades at 399.5 times earnings.
Its beta is 0.15: it tends to move less than the market.
About the company
Astec LifeSciences Ltd. is a prominent entity within the chemical sector, specifically focusing on the production of agrochemical active ingredients. The company plays a crucial role in the agricultural industry by manufacturing a variety of products that enhance crop protection and yield.
Want to see everything about Astec LifeSciences?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Astec LifeSciences do?
Astec LifeSciences Ltd. is a prominent entity within the chemical sector, specifically focusing on the production of agrochemical active ingredients. The company plays a crucial role in the agricultural industry by manufacturing a variety of products that enhance crop protection and yield.
What is the chance ASTEC.NSE goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, ASTEC.NSE ends the month between ₹576.99 and ₹721.57.
How big is Astec LifeSciences and what is its P/E ratio?
Astec LifeSciences's market capitalization is ₹15.5B. Its price-to-earnings (P/E) ratio is 399.5: you pay ₹399.5 for each ₹1.00 of yearly earnings.
Does Astec LifeSciences pay a dividend?
Yes. ASTEC.NSE's current dividend yield is 0.86% at today's price (₹652.85).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer